Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
复制标题
DOI：
10.1136/bmj.b2700
复制
发表时间：
2009-08-18
影响因子：
39.2
通讯作者：
Altman, Douglas G.
中科院分区：
文献类型：
--
作者：
Moher, David;Liberati, Alessandro;Altman, Douglas G.
系统评价和荟萃分析对于准确可靠地总结与医疗保健干预措施的有效性和安全性相关的证据至关重要。然而，这些报告的清晰度和透明度并不是最佳的。系统评价的不良报告会降低其对临床医生、政策制定者和其他用户的价值。自从 QUOROM（荟萃分析报告质量）声明（1999 年发布的报告指南）制定以来，在系统评价和荟萃分析的实施和报告方面已经取得了一些概念、方法和实践方面的进展。此外，对已发表的系统评价的回顾发现，有关这些研究的关键信息往往报道得很少。意识到这些问题，一个由经验丰富的作者和方法学家组成的国际小组开发了 PRISMA（系统评价和荟萃分析的首选报告项目），作为对医疗保健干预措施评估进行系统评价和荟萃分析的原始 QUOROM 指南的演变。PRISMA 声明由 27 项清单和四阶段流程图组成。该清单包括被认为对于系统评价的透明报告至关重要的项目。在这份解释和阐述文件中，我们解释了每个清单项目的含义和基本原理。对于每个项目，我们都提供了良好报告的示例，并在可能的情况下引用了相关的实证研究和方法论文献。 PRISMA 声明、本文件和相关网站 (www.prisma-statement.org/) 应成为改进系统评价和荟萃分析报告的有用资源。系统评价应建立在描述评价的基本原理、假设和计划方法的协议之上；很少有评论报告是否存在协议。详细、描述良好的方案可以促进对审查方法的理解和评估，以及在已完成的审查中检测方法的修改和选择性报告。我们描述了报告指南、2015 年方案系统评价和荟萃分析的首选报告项目 (PRISMA-P 2015) 的制定。 PRISMA-P 包含 17 项清单，旨在促进系统评价的稳健方案的准备和报告。资助者和委托审查者可能会考虑强制使用清单，以方便在资助申请中提交相关方案信息。同样，同行评审员和编辑可以使用该指南来衡量提交在期刊或其他媒体上发表的系统评审方案的完整性和透明度。
Systematic reviews and meta-analyses are essential to summarise evidence relating to efficacy and safety of healthcare interventions accurately and reliably. The clarity and transparency of these reports, however, are not optimal. Poor reporting of systematic reviews diminishes their value to clinicians, policy makers, and other users.Since the development of the QUOROM (quality of reporting of meta-analysis) statement-a reporting guideline published in 1999-there have been several conceptual, methodological, and practical advances regarding the conduct and reporting of systematic reviews and meta-analyses. Also, reviews of published systematic reviews have found that key information about these studies is often poorly reported. Realising these issues, an international group that included experienced authors and methodologists developed PRISMA (preferred reporting items for systematic reviews and meta-analyses) as an evolution of the original QUOROM guideline for systematic reviews and meta-analyses of evaluations of health care interventions.The PRISMA statement consists of a 27-item checklist and a four-phase flow diagram. The checklist includes items deemed essential for transparent reporting of a systematic review. In this explanation and elaboration document, we explain the meaning and rationale for each checklist item. For each item, we include an example of good reporting and, where possible, references to relevant empirical studies and methodological literature. The PRISMA statement, this document, and the associated website (www.prisma-statement.org/) should be helpful resources to improve reporting of systematic reviews and meta-analyses.Systematic reviews should build on a protocol that describes the rationale, hypothesis, and planned methods of the review; few reviews report whether a protocol exists. Detailed, well-described protocols can facilitate the understanding and appraisal of the review methods, as well as the detection of modifications to methods and selective reporting in completed reviews. We describe the development of a reporting guideline, the Preferred Reporting Items for Systematic reviews and Meta-Analyses for Protocols 2015 (PRISMA-P 2015). PRISMA-P consists of a 17-item checklist intended to facilitate the preparation and reporting of a robust protocol for the systematic review. Funders and those commissioning reviews might consider mandating the use of the checklist to facilitate the submission of relevant protocol information in funding applications. Similarly, peer reviewers and editors can use the guidance to gauge the completeness and transparency of a systematic review protocol submitted for publication in a journal or other medium.